Cian Healthcare Ltd.
Snapshot View

15.80 -0.80 ▼-4.8%

07 October 2022, 04:01:00 PM
Volume: 10,000

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.cian.co
Market Cap 39.49 Cr.
Enterprise Value(EV) 107.51 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) -2.21 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-03
Industry PE 31.91 Trailing Twelve Months Ending 2022-03
Book Value / Share 22.21 Trailing Twelve Months Ending 2022-03
Price to Book Value 0.71 Calculated using Price: 15.80
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 2.50 Cr. 24,995,764 Shares
FaceValue 10
Company Profile
The Company develops, manufactures and commercializes pharmaceutical products including sales, marketing, quality assurance, distribution, compliance and regulatory aspects under 12 therapeutic segments like Orthopaedics, Gynaecology, Paediatrics, Cardiac, Diabetic, Dermatology, Pain Management, Antibiotics, Neuro, Critical Care, Gastro-Intestinal and Nutraceuticals, along with 10 sales division focused on developing and growing its engagements in specialist and super specialist division. The company works under different business models like Brand Business, Export, Third Party Manufacturing and Government Supplies. The Company manufactures innovative products comprising of Tablets, Capsules, Liquid Orals, Ointments, Creams, Lotions, Gels and Sachet. The Company has special licence for manufacturing veterinary products for client like SAVAvet and Venky's.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-4.82%
1 Week
-12.22%
1 Month
-13.90%
3 Month
-33.61%
6 Month
-22.74%
1 Year
-24.76%
2 Year
+23.44%
5 Year
10 Year
2 years 2020-03 2021-03
Return on Equity (%) -7.54 0.10
Return on Capital Employed (%) 3.00 6.99
Return on Assets (%) -2.42 0.03

Balance Sheet View Details >>

Particulars 2 years 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 58 58
Non Curr. Liab. 50 41
Curr. Liab. 48 58
Minority Int.
Equity & Liab. 157 157
Non Curr. Assets 94 88
Curr. Assets 54 63
Misc. Exp. not W/O 8 5
Total Assets 157 157

Profit Loss View Details >>

Particulars 2 years 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 57 74
Other Income 1 0
Total Income 58 74
Total Expenditure -50 -62
PBIDT 8 12
Interest -7 -8
Depreciation -4 -3
Taxation 0 -1
Exceptional Items 0 0
PAT -4 0
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit -4 0
Adjusted EPS -2 0

Cash Flow View Details >>

Particulars 2 years 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. -7 6
Cash Fr. Inv. -27 3
Cash Fr. Finan. 36 -10
Net Change 1 -1
Cash & Cash Eqvt 3 2

Shareholding Pattern View Details >>

8 Qtrs 2018-09 (%) 2019-09 (%) 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 96.60 70.89 70.89 70.89 70.89 70.89 66.26 66.26
Public 3.40 29.11 29.11 29.11 29.11 29.11 33.74 33.74
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 10.14 10.14 10.14 10.14 20.14 14.11 34.11

Announcements View Details >>

Fri, 07 Oct 2022
Quarterly Disclosures By Listed Entities Of Defaults On Payment Of Interest/ Repayment Of Principal Amount On Loans From Banks / Financial Institutions And Unlisted Debt Securities
Quarterly Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount on loans from banks / financial institutions and unlisted debt securities
Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
DECLARATION OF REMOTE E- VOTING AND POLL VOTING RESULTS IN COMPLIANCE WITH REGULATION 44 (3) OF SEBI (LODR) REGULATIONS 2015.
Fri, 30 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
CORPORATE ANNOUNCEMENT FOR OUTCOME OF 19TH ANNUAL GENERAL MEETING FOR THE FINANCIAL YEAR 2021-22 HELD ON FRIDAY 30TH DAY OF SEPTEMBER 2022.

Technical Scans View Details >>

Thu, 06 Oct 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Low Close Crossing Last Month Low
Opening at Low Opening at Low
Closing Below Previous Low Closing Below Previous Low
High Decrease 1 Month High Decrease 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,656.62 953.00 -0.1%
Divi's Laboratories Ltd. 99,250.74 3,738.70 +0.0%
Cipla Ltd. 91,332.41 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 72,821.94 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,207.02 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 53,000.56 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,689.71 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.79 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.96 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.70 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.35 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.55 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 66.17 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.66 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.56 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.25 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.60 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.64 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.29 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.54 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Cian Healthcare Ltd.

What is Cian Healthcare share price?

Can I buy Cian Healthcare shares now?

What is the Market Cap of Cian Healthcare?

What are the key metrics to analyse Cian Healthcare?

What is the 52 Week High and Low of Cian Healthcare?

What is the trend of Cian Healthcare share price?